ArticleACM transactions on computing for healthcare2026
Federated Choquet Regression with LASSO for Outcome Prediction in Multisite Longitudinal Trial Data.
Article in ACM transactions on computing for healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Aggregating person-level data across multiple clinical study sites is often constrained by privacy regulations, necessitating the development of decentralized modeling approaches in biomedical research. To address this requirement, a federated nonlinear regression algorithm based on the Choquet integral has been introduced for outcome prediction. This approach avoids reliance on prior statistical assumptions about data distribution and captures feature interactions, reflecting the non-additive nature of biomedical data characteristics. This work represents the first theoretical application of Choquet integral regression to multisite longitudinal trial data within a federated learning framework. The Multiple Imputation Choquet Integral Regression with LASSO (MIChoquet-LASSO) algorithm is specifically designed to reduce overfitting and enable variable selection in federated learning settings. Its performance has been evaluated using synthetic datasets, publicly available biomedical datasets, and proprietary longitudinal randomized controlled trial data. Comparative evaluations were conducted against benchmark methods, including OLS regression and Choquet OLS regression, under various scenarios such as model misspecification and both linear and nonlinear data structures in non-federated and federated contexts. MSE was used as the primary performance metric. Results indicate that MIChoquet-LASSO outperforms compared models in handling nonlinear longitudinal data with missing values, particularly in scenarios prone to overfitting. In federated settings, Choquet OLS underperforms, whereas the federated variant of the model, FEDMIChoquet-LASSO, demonstrates consistently better performance. These findings suggest that FEDMIChoquet-LASSO offers a reliable solution for outcome prediction in multisite longitudinal trials, addressing challenges such as missing values, nonlinear relationships, and privacy constraints while maintaining strong performance within the federated learning framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.